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Background
Epidemiological and animal data are clear that early first
pregnancy decreases subsequent breast cancer risk. The
mechanism for this decrease however is less clear and sev-
eral hypotheses abound. One possibility that has not
received any attention is the physiology of fluid secretion
in the breast. The ductal systems have secretions which
can be accessed either through nipple aspiration or ductal
lavage. It is not clear whether the mechanisms identified
for absorption, secretion, concentration and local synthe-
sis that have been described in the lactating breast are con-
sistently available to the non lactating breast or whether
there is a difference in nulliparous and parous women. It
is not clear whether the known changes to the ductal-alve-
olar system with the first pregnancy remain permanent or
have long lasting ramifications. The hypothesis tested was
that the first pregnancy permanently changes the physiol-
ogy of the ductal epithelial membrane transport. Two
known drug transport mechanisms in lactating women
were tested using caffeine and cimetidine.
Methods
A total of 14 women were recruited for this IRB-approved
prospective study to undergo blood collection, nipple
aspiration and ductal lavage five times over 12 hours. Of
these women, 5 were postmenopausal and 9 were pre-
menopausal; 8 were parous and 6 nulliparous. Subjects
were asked to abstain from caffeine and cimetidine for 24
hours prior to participation. After a baseline was recorded;
subjects were then given 200 mg of caffeine (NoDoz) and
200 mg of cimetidine (Tagamet) and the procedure was
repeated at set time points 4 more times over 12 hours.
Samples were sent to a central laboratory for analysis
where caffeine and cimetidine were quantified in serum,
nipple aspirate fluid (NAF) and lavage.
Results
There were significant and intriguing results regarding the
differences between the "resting" or non lactating breast
and the lactating breast. In lactating women caffeine pas-
sively diffuses into milk rapidly and reflects serum levels.
In resting breasts caffeine levels generally peak at 6 hours
or later after ingestion. Cimetidine, on the other hand, is
known to be concentrated in milk in the lactating woman
but was not detected in ductal fluid from the resting
breast. Since cimetidine is known to be actively trans-
ported in the lactating woman, this pattern is consistent
with a transporter protein which is transcribed only dur-
ing lactation. The concentrations and time course of drugs
in NAF and DL also seem to differ suggesting some phys-
iological difference other than dilution. There was a sig-
nificant difference between parous and nulliparous
women in terms of caffeine concentrations and uptake.
Finally preliminary analyses of injected mannitol into
breast ducts are still undergoing investigation to better
understand the bidirectional transfer of drugs.
Conclusion
Our study has reinforced our opinion that the physiology
of the "resting" breast is understudied and the transport
mechanisms of drugs, vitamins or other nutrients in the
non-lactating breast may be very different than the known
mechanisms in a lactating woman. While different trans-
port mechanisms, including passive diffusion, carrier-
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mediated and transcytosis have been identified in the lac-
tating breast no one that we are aware of has studied these
routes in the female "resting" breast. Our pilot data with
three drugs has lead to more questions than answers that
we plan on probing further. This information is not only
critical for potential understanding of systemic drug deliv-
ery to the breast for prevention or early intervention but
also for the growing field of intraductal therapy.
Acknowledgements
Grant funded by the Avon Foundation